Release Date: 22/02/21 10:05 Summary: NTA Estimate - $0.1425 Price Sensitive: No Download Document 187.18KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%